Evidence map›Paper›PMID 27171743›Full record

ArticleJournal of acquired immune deficiency syndromes (1999)2016

D-Dimer Levels and Traditional Risk Factors Are Associated With Incident Hypertension Among HIV-Infected Individuals Initiating Antiretroviral Therapy in Uganda.

Samson Okello, Stephen B Asiimwe, Michael Kanyesigye, Winnie R Muyindike, Yap Boum, Bosco B Mwebesa, Jessica E Haberer, Yong Huang, Kenneth Williams, Tricia H Burdo and 6 more

Open access · greenAbstract read
In one paragraph

Article in Journal of acquired immune deficiency syndromes (1999), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 4 pooled it
4.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 4 syntheses or guidelines pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Review
  8. Article
  9. Review
  10. Article
  11. Observational
  12. Article
  13. Immunology of Hypertension in People With HIV.Journal of the American Heart Association · 2020
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 2 countries.

Samson Okello*Department of Internal Medicine, Mbarara University of Science and Technology, Mbarara, Uganda; †Department of Epidemiology, Harvard T.H Chan School of Public Health, Boston, MA; ‡Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA; §Epicentre Mbarara Research Centre, Mbarara, Uganda; ‖Center for Global Health, Massachusetts General Hospital, Boston, MA; ¶Harvard Medical School, Massachusetts General Hospital, Boston, MA; #Department of Bioengineering and Therapeutic Sciences, School of Pharmacy, University of California, San Francisco, CA; **Department of Biology, Boston College, Chestnut Hill, MA; ††Department of Pathology and Laboratory Medicine, University of Vermont, Burlington, VT; ‡‡Department of Global Health and Populations, Harvard T.H Chan School of Public Health, Boston, MA; and §§Department of Medicine, University of California, San Francisco, CA.
Stephen B Asiimwe
Michael Kanyesigye
Winnie R Muyindike
Yap Boum
Bosco B Mwebesa
Jessica E Haberer
Yong Huang
Kenneth Williams
Tricia H Burdo
Russell P Tracy
David R Bangsberg
A Rain Mocello
Jeffrey N Martin
Peter W Hunt
Mark J Siedner
University of California, San Francisco · USMassachusetts General Hospital · USMbarara University of Science and Technology · UGBoston College · USEpicentre Uganda · UGHarvard University · USUniversity of Vermont · US

Funding

Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STEVEN Grant DEEKS · 1988 to 2026
$93.6M
AIDS and Cancer Specimen Resource (ACSR)UM1CA181255 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Jeffrey Michael Bethony, Anna Coghill · 2013 to 2026
$56.7M
WADA (West Africa Database on Antiretroviral Therapy) CollaborationU01AI069919 · NIAID · UNIVERSITY OF BORDEAUX II · PI Didier Koumavi Ekouevi, Antoine Jaquet · 2006 to 2026
$29.9M
TB PREVENTION AND HIV IN THE HOMELESS--AN INTERVENTIONR01MH054907 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BANGSBERG, DAVID ROY · 1995 to 2014
$20.7M
Behavioral Aspects of Low-cost Medical Devices to Improve HIV CareK23MH099916 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI SIEDNER, MARK J · 2013 to 2017
$917k
IDO-induced Tryptophan Catabolism and Mortality in Treated HIV-infected AfricansR56AI100765 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HUNT, PETER W · 2012 to 2012
$450k
Innate Immune Response Genetics and T cell Activation in Treated HIV InfectionR21AI078774 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HUNT, PETER W · 2009 to 2010
$414k
Epidemiology of atherosclerosis among older-age individuals with HIV in UgandaR21HL124712 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI SIEDNER, MARK J · 2014 to 2015
$332k
NCI NIH HHS UM1 CA181255NHLBI NIH HHS R21 HL124712NIAID NIH HHS P30 AI027763NIAID NIH HHS R21 AI078774NIAID NIH HHS R56 AI100765NIAID NIH HHS U01 AI069919NIMH NIH HHS K23 MH099916NIMH NIH HHS R01 MH054907
6 · The paper itself

Abstract

objectivesWe sought to describe blood pressure (BP) changes after antiretroviral therapy (ART) initiation and evaluate the association of markers of inflammation with incident hypertension in a cohort of HIV-infected individuals in Uganda.

methodsWe used mixed effects linear regression to model changes in systolic BP over time among a cohort of HIV-infected individuals initiating ART in Uganda. After exclusion of participants with preexisting hypertension, we identified participants with normal BP throughout follow-up (controls) and those with elevated BP on ≥3 consecutive visits (cases). Before ART initiation, participants had testing for interleukin 6, kynurenine/tryptophan ratio, lipopolysaccharide, soluble CD14, soluble CD163, and D-dimer and those with viral suppression at 6 months during ART had repeat tests. We fit logistic regression models to estimate associations between biomarkers and risk of incident hypertension.

resultsIn the entire cohort, systolic BP increased by 9.6 mm Hg/yr (95% CI: 7.3 to 11.8) in the first 6 months of ART, then plateaued. Traditional factors: male gender (adjusted odds ratio (AOR) 2.76, 95% CI: 1.34 to 5.68), age (AOR 1.09, 95% CI: 1.04 to 1.13), overweight (AOR 4.48, 95% CI: 1.83 to 10.97), and a CD4 count <100 cells (AOR 3.08, 95% CI: 1.07 to 8.89) were associated with incident hypertension. After adjusting for these, D-dimer levels at month 6 were inversely associated with incident hypertension (AOR 0.61, 95% CI: 0.37 to 0.99). Although not significant, similar associations were seen with sCD14 and kynurenine/tryptophan ratio.

conclusionBP increases early after ART initiation in Ugandans. Traditional risk factors, rather than immune activation, were associated with incident hypertension in this population.

Indexed as

AdultAnti-HIV AgentsAntihypertensive AgentsFemaleFibrin Fibrinogen Degradation ProductsHIV InfectionsHumansHypertensionMaleRisk FactorsAnti-HIV AgentsAntihypertensive AgentsFibrin Fibrinogen Degradation Productsfibrin fragment D

Identifiers

PMID27171743
PMCPMC5085880
OpenAlexW2367583732

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.